Back to search
Cholestasis, Intrahepatic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cholestasis, Intrahepatic trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cholestasis, Intrahepatic trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The present phase 1b/2 randomised, double-blind, placebo-controlled, two-part study is designed to evaluate the safety, tolerability, pharmacokinetic characteri…
In patients with Alagille syndrome (ALGS), the key objectives are to evaluate the tolerability, long-term safety (including possible liver toxicity) and long-te…
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver). PBC is a slowly progressive disease…
The purpose of this study is to assess the long-term safety and effectiveness of odevixibat in participants with Alagille syndrome (ALGS). The participants of…
This study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a p…
Study to investigate the efficacy and safety of two doses of K-808 (pemafribate) in subjects with PBC.
The primary objective of this open label extension study is to evaluate the long-term safety and tolerability of maralixibat.